Clinical Trial Update: Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and immunogenicity of an HIV vaccine (gp145 C.6980) in healthy, HIV-uninfected adults in the United States has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• gp145 C.6980 HIV vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2021-07-27